CAR T-Cell Therapy

Make an Appointment
You have been seen by a Duke oncology provider within the last three years or you need to reschedule an appointment.

or call

919-668-6688
Overview

Chimeric Antigen Receptor (CAR) T-Cell therapy is a personalized immunotherapy that uses your own cells to fight advanced lymphomas. It may be recommended when at least two other treatments have not been effective. Duke is one of three North Carolina centers certified to administer two FDA-approved CAR T-cell therapies for non-Hodgkin lymphoma: Yescarta and Kymriah. Kymriah is also approved for treatment of leukemia in pediatric patients and young adults.